Search
-
Brexit and the UK Pharma Industry
The ‘In’ and ‘Out’ campaigns are now intensifying, but ‘Brexit’ has been a constant topic of conversation since the referendum date was announced 3 months ago. A British exit could have widespread repercussions for many sectors within the UK economy, especially in highly regulated and controlled industries such as pharmaceuticals.
-
It’s Nativism: Explaining the Drivers of Trump’s Popular Support
A year ago who would have believed it—Trump the presumptive nominee for the Republican party! For the longest time, most expected Trump would implode. But to the prognosticators chagrin this did not happen.
-
Ipsos Healthcare Launches SyndicatedPD-L1Testing Monitor in Oncology
Ipsos Healthcare – the global healthcare division of Ipsos – has launched the syndicated PD-L1 Testing Monitor, a timely addition to the Ipsos Oncology Molecular Diagnostics Portfolio.
-
Taking Responsibility - Marco Pietrobono
Today, the focus is on the Marco Pietrobono charity in Italy.
-
How Australia Eats, Thinks About And Shops For Food
This study reveals the actual food attitudes and behaviour of everyday Australians.
-
Brazil Pulse - Consumer’s Confidence Has Reached the Lowest Level - April 2016
The high disapproval of Dilma Roussef’s administration and the country’s erroneous direction result in nearly 60% of support for the impeachment - which is lower (43%) in classes D and E.
Consumer’s confidence has reached the lowest level considering all the historical series, and is at 64 points.
A country in economic depression, political instability and injured pride. What are the main problems to be solved to revert this situation? -
Food, Beverage and Consumer Insights in China
This report reveals the latest developments in eating and drinking in China, from attitudes on organic produce, to innovation and personalising the packaging and even the product itself.
-
Who Will Win the Race to Treat NASH?
Non-alcoholic Steatohepatitis, or NASH, is a liver disease characterized by rising prevalence, low diagnosis and a lack of therapies approved for treatment. All of these factors combine to make NASH a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. Accordingly, the race is now on among several pharma companies to develop the first effective pharmacotherapy to treat NASH.
-
Pneumonia: A View From Europe
This study looks at awareness and perceptions of Pneumonia among the 50+ population in nine European markets.
-
China Pulse - March 2016
China’s economy showed moderate but steady growth with a year-on-year GDP increase of 6.93 percent at comparable prices in Q3 2015.